« Two upcoming events |
| New Ninth Circuit decision on the UCL's extraterritorial operation: Sullivan v. Oracle Corp. »
As expected, a petition for review was filed last week in the latest class certification/collateral estoppel case, Johnson v. GlaxoSmithKline, Inc., no. S167892.
Here is my original post on the Court of Appeal's opinion, Johnson v. GlaxoSmithKline, Inc., 166 Cal.App.4th 1497 (2008) (modified Oct. 14, 2008) (Second Appellate District, Division Seven).
Posted by Kimberly A. Kralowec at 06:00 AM in Class actions - Supreme Court | Permalink
The comments to this entry are closed.
Enter your email address:
Delivered by FeedBurner